CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Sonova raises full-year forecasts on market share gains, product launches

By Reuters News

By Amir Orusov and Anastasiia Kozlova

Nov 12 (Reuters) - Swiss hearing aid maker Sonova SOON.S on Thursday raised its sales and profit forecasts for its 2027 financial year, citing market share gains and solid uptake of new products.

Sonova shares, which have gained nearly 36% so far this year, were indicated to rise more than 3% in premarket trading.

The world's largest maker of hearing aids expects its sales to rise by 6% to 8% in local currencies, up from a previous forecast of 5% to 8%, and core operating profit to grow 10% to 13%, compared with 7% to 10% previously, in the year through March 2027.

The upgrade comes as demand across the hearing-aid industry remains robust and provides an early indication of the commercial success of Sonova's AI-powered Phonak EON platform, seen as a key driver of its medium-term growth targets.

"We see AI as an amazing opportunity and believe we are ahead of the curve," CEO Eric Bernard told Reuters, adding that increasingly software-based solutions were creating more opportunities for regular upgrades and innovation.

Bernard said EON had received a "very good reception" and was already contributing above the company's expectations, although its impact on first-half results was limited as the platform was launched only towards the end of the period.

"The speed of conversion from (previous platform) Ultra to EON is going very, very fast. People are embracing the product," he said.

Sonova also raised its forecast for global hearing-aid market growth to 3% to 5% this year, versus 2% to 4% previously, reflecting stronger industry conditions.

https://www.reuters.com/graphics/HEARING-STOCK/zjpqlrmravx/chart.png

Sales in the Asia-Pacific region, a key longer-term growth market for Sonova due to low hearing aid penetration and favourable demographics, grew 11.4% to 186.9 million Swiss francs ($224.4 million) in the first half of the year, driven by strong demand in Australia, China and Japan.

($1 = 0.8329 Swiss francs)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.